KRT5 and adenocarcinoma: CK5/6 expression was present in 45 of 65 (69.2%) epithelioid mesothelioma, and 55 of 56 (98.2%) squamous cell carcinoma, and 13 of 60 (21.7%) adenocarcinoma.